Decreased pain tolerance and mood in recreational users of MDMA
- 139 Downloads
3,4-Methylenedioxymethamphetamine (MDMA) is known to affect brain serotonin (5-HT) neurons in experimental animals. However, its effects on humans are more difficult to infer. Serotonin is implicated in the body’s ability to modulate the effects of pain and to regulate mood.
The aim of this research is to test nociceptive responses and mood in MDMA users as an index of central 5-HT function.
Measurements of pain tolerance were obtained using the cold-pressor test for 15 polydrug users who regularly use MDMA, 3–4 days after the most recent usage, and ten matched polydrug users who do not use MDMA. A rating on mood was obtained for each participant using the Nowlis Mood Adjective checklist.
Measurements of pain tolerance and mood were significantly lower in the MDMA group. A positive correlation between mood and pain tolerance was found in the MDMA group, whereas no correlation was found between these variables in the non-MDMA group
This study found an association between pain tolerance and MDMA usage and confirmed the association between MDMA and depressed mood. The current results suggest that MDMA, at least in the short term, may cause serotonin-mediated alterations in pain sensitivity.
KeywordsMDMA Serotonin Nociception Pain tolerance Mood
- Davison D, Parrott AC (1997) Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects. Hum Psychopharmacol Clin Exp 12:221–226Google Scholar
- Gerra G, Zaimovic A, Ampollini R, Giusti F, Delsignore R, Raggi MA, Laviola G, Macchia T, Brambilla F (2001) Experimentally induced aggressive behaviour in subjects with 3,4-methylenedioxymethamphetamine (“ecstasy”) use history: psychobiological correlates. J Subst Abuse 13:471–491Google Scholar
- Hellström B, Lundberg U (2000) Pain perception to the cold pressor test during the menstrual cycle in relation to estrogen levels and a comparison with men. Int Physiol Behav Sci 35:130–139Google Scholar
- Maldonado E, Navarro JF (2000) Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box. Prog Neuropsychopharmacol Biol Psychiatry 24:463–472Google Scholar
- Merrill J (1996) Ecstasy and neurodegeneration: advice is that “less is more”. BMJ 313:423Google Scholar
- Nowlis V (1965) Research with the mood adjective checklist. In: Tomkins SS, Izard CE (eds) Affect, cognition and personality. Springer, New YorkGoogle Scholar
- Parrot AC (2001) Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16:557–577Google Scholar
- Solowij N (1993) Ecstasy (3,4-methylenedioxymethamphetamine). Curr Opin Psychiatry 6:411–415Google Scholar
- Teicher MH, Andersen SL (1999) Limbic serotonin turnover plunges during puberty. Poster presented at the Meeting of the Society for Neuroscience, MiamiGoogle Scholar
- Zimmerman M (1984) Basic concept of pain and pain therapy. Drug Res 34:1053–1059Google Scholar